Variant report
Variant | esv1812353 |
---|---|
Chromosome Location | chr6:54554502-54557193 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:54556132..54558033-chr6:54708676..54711461,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4715468 | chr6:54554502-54554503 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs373798829 | chr6:54554520-54554521 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs2089411 | chr6:54554627-54554628 | Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs139455541 | chr6:54554665-54554666 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs80170592 | chr6:54554676-54554677 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs553227494 | chr6:54554685-54554686 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
7 | rs111826127 | chr6:54554686-54554687 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
8 | rs58010645 | chr6:54554693-54554694 | Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs77313317 | chr6:54554728-54554729 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs77162107 | chr6:54554729-54554730 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
11 | rs532528782 | chr6:54554730-54554731 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
12 | rs552638136 | chr6:54554756-54554757 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
13 | rs57961192 | chr6:54554971-54554972 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
14 | rs62414273 | chr6:54554983-54554984 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
15 | rs531606008 | chr6:54554985-54554986 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
16 | rs548132116 | chr6:54554988-54554989 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
17 | rs183165252 | chr6:54554997-54554998 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
18 | rs534187212 | chr6:54555004-54555005 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
19 | rs554103764 | chr6:54555032-54555033 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
20 | rs386701316 | chr6:54555034-54555035 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
21 | rs6906010 | chr6:54555036-54555037 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs187078798 | chr6:54555055-54555056 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
23 | rs576162590 | chr6:54555057-54555058 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
24 | rs541872356 | chr6:54555066-54555067 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
25 | rs35030193 | chr6:54555115-54555116 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
26 | rs2894821 | chr6:54555116-54555117 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs541298029 | chr6:54555139-54555140 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
28 | rs571515530 | chr6:54555203-54555204 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
29 | rs149749605 | chr6:54555226-54555227 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
30 | rs534527137 | chr6:54555234-54555235 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
31 | rs192033239 | chr6:54555312-54555313 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
32 | rs560387754 | chr6:54555314-54555315 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
33 | rs182986924 | chr6:54555339-54555340 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
34 | rs368356862 | chr6:54555381-54555382 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
35 | rs74839993 | chr6:54555388-54555389 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
36 | rs74667765 | chr6:54555453-54555454 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs558918841 | chr6:54555506-54555507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs147423988 | chr6:54555534-54555535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528894421 | chr6:54555555-54555556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs374421476 | chr6:54555576-54555577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs548065150 | chr6:54555579-54555580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs925054 | chr6:54555590-54555591 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs78186206 | chr6:54555628-54555629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs556455351 | chr6:54555666-54555667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs569786315 | chr6:54555722-54555723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs187749219 | chr6:54555724-54555725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs555431016 | chr6:54555767-54555768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs368585022 | chr6:54555783-54555784 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs80222287 | chr6:54555790-54555791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs925053 | chr6:54555791-54555792 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Neurocytoma | 17123091 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Neuroblastoma | 19686582 | CNVD |
Neuroblastoma | 17289879 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:54554000-54554800 | Bivalent Enhancer | HUES64 Cell Line | embryonic stem cell |
2 | chr6:54554000-54555200 | Bivalent Enhancer | HUES48 Cell Line | embryonic stem cell |
3 | chr6:54554400-54554600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr6:54554600-54554800 | Bivalent Enhancer | iPS-18 Cell Line | embryonic stem cell |
5 | chr6:54554600-54555000 | Bivalent Enhancer | HUES6 Cell Line | embryonic stem cell |
6 | chr6:54554600-54555400 | Bivalent Enhancer | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr6:54554800-54555600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr6:54554800-54556200 | Enhancers | Stomach Mucosa | stomach |
9 | chr6:54556200-54557200 | Weak transcription | Stomach Mucosa | stomach |